Conference PaperPDF Available

Peri-implantitis etiology, diagnosis and management

Authors:
Peri-implantitis
Hotel Monroe Beirut - Lebanon
21 September 2010
ITI Middle East Section Meeting
Introduction
Definition and
clinical diagnosis
Management
Prevention
Oral implants have enjoyed high clinical success rates over the last decade,
with an explosion of numerous surfaces and designs of implants all claiming
to have superior quality over another.
Introduction
It should be recognized however, that clinical complications or failures do
occur and as such, a challenge is posed to the clinician in terms of initial
diagnosis of peri-implant diseases and subsequent management.
A peri-implant disease is a descriptive term used to describe a non specific
inflammatory reaction in the host tissues.
Introduction
“Peri-implantitis” should be distinguished from “peri-implant mucositis” in
that the former is defined as, “an inflammatory reaction with loss of
supporting bone in the tissues surrounding a functioning implant”,4 while
the latter involves a reversible inflammation localized to the soft tissues
only.
Peri-implantitis may display some or all of the following symptoms;
bleeding on probing, increased probing pocket depth, mobility, suppuration
and pain.
Introduction
The trends show that there is a cluster phenomenonwhereby peri-
implantitis failures tend to occur in a subset of patients, similar to that seen in
chronic periodontitis.**
A systematic review of the incidence of biological and technical complications in implant dentistry reported
in prospective longitudinal studies of the last 5 years. (Berglund T, Person L, Kline B. J Clin Periodontal 2002;
** A long term survey of tooth loss in 600 treated periodontal patients. (Hirschfield L, Wasserman B. J
Periodontal 1978
Introduction
The incidence of peri-implantitis is quite rare, ranging from 2-10%.*
Though this condition is somewhat rare at present, there is little doubt
that as the length of time of implants in vivo increases, the incidence of
this condition will also increase.
There is a statistically significant higher incidence of periimplantitis for
implants placed in patients with a history of chronic periodontitis (28.6%)
compared with periodontally healthy individuals (5.8%).* The correlation
between the presence of periodontitis and the development of peri
implantitis has been supported by a recent systematic review.**
*Kotsovilis S, Karoussis IK, Trianti M, Fourmousis I. Therapy of peri
implantitis: a systematic review. J Clin Periodontol 2008; 35: 621629.
**Renvert S, Persson GR. Periodontitis as a potential risk factor for peri
implantitis. J Clin Periodontol 2009; 36 (Suppl. 10): 914.
Introduction
Therefore it is not surprising that the treatments suggested for peri-implantitis
are based on the available evidence on the treatment of periodontitis.
Peri-implant diseases: Consensus Report of the Sixth European Workshop on
Periodontology. 2008 Jan Lindhe, Joerg Meyle.
Introduction
Management of perimplantitis generally works on the assumption that there
is a primary microbial etiology. Furthermore, it is assumed that micro-
organisms and/or their byproducts lead to infection of the surrounding tissues
and subsequent destruction of the alveolar bone surrounding an implant. *
* Mombelli A. Microbiology and antimicrobial therapy of peri-implantitis. Periodontol
2000 2002; 28:177-189.
Introduction
Definition
Inflammatory reaction in the mucosa surrounding an implant with signs of loss
of supporting bone.
(Zitzmann & Berglundh 2008 Journal of Clinical Periodontology 6'Th European workshop
on Periodontology)
Peri-implantitis
Diagnosis of peri-implantitis relies on crude parameters commonly used for
the diagnosis of periodontal diseases.
Typical signs and symptoms of peri-implantitis include; *
Clinical Diagnosis
* Etiology, diagnosis, and treatment considerations in peri-implantitis. (Mombelli, A. Curr- O pin
Periodontal 1997; 4:127-136)
** The diagnosis and treatment of peri-implantitis.( Mombelli A, Lang NP..
Periodontal 2000 1998; 17:63-76)
Evidence of vertical destruction of the
crestal bone.
Formation of a peri-implant pocket (>
4mm),
Bleeding or suppuration after gently
probing,
Tissue redness and swelling
Mobility (insensitive in detecting early
implant failure).
Clinical Diagnosis
Clinical signs of peri-implantitis may not always be evident. Standardized
radiographs are suggested one year after fixture placement and every
alternate year thereafter.*
Dental implants:
maintenance, care and
treatment of peri-implant
infection.
Chen S, Darby I. Aust
Dent J 2003; 48(4):212-
220.
Clinical Diagnosis
Microbiology
Numerous animal and human studies have clearly shown that bacterial
plaque which is allowed to build up on implants leads to inflammatory
changes of the adjacent soft tissues.
An early study, which compared the microbiota surrounding successful and
failing titanium implants found that failing sites had a significantly higher
proportion of micro-organisms traditionally associated with periodontal
diseases.
The relationship between these inflammatory changes in the soft tissues
and subsequent progression to involve bone loss that is observed in peri-
implantitis is not clarified.
Gram negative anaerobic rods, spirochaetes and fusiform bacteria were found
in higher proportions at peri-implantitis sites as compared with healthy sites,
which were predominantly composed of coccoid forms.*
Microbiology
The clinical implication is, if traditional periodontal pathogens are found, then
the disease process could be similar to periodontal disease and patients
with a history of chronic periodontitis may be at increased risk of peri-
implantitis. It is suggested, that the microbiology associated with implants
are related to the bacteria already resident in the oral cavity, that is, that the
remaining teeth can act as reservoirs for seeding of bacteria in the peri-
implant tissues.
* Mombelli A, Van Oosten MAC, Schurch E, Lang NP. The microbiota associated with
successful or failing osseointegrated titanium implants. Oral Microbial Immanuel 1987;
2:145-151.
Traditional periodontal pathogens such as Porphyromonas gingivalis (Pg),
Actinomyces actinomycetemcomitans (Aa) and Prevotella intermedia (Pi)
have been shown to colonize the peri-implant sulcus from 1 to 3 months
after exposure to the oral environment.*
Microbiology
Management
An explosion of human and animal studies in the last 20 years has addressed
the issue of treatment of peri-implant infections, with little scientific evidence to
support a specific treatment modality (for review see Roos-Jansåker et al.
2003).34 Management of periimplantitis generally works on the assumption
that there is a primary microbial etiology.
Furthermore, it is assumed that micro-organisms and/or their byproducts
lead to infection of the surrounding tissues and subsequent destruction of
the alveolar bone surrounding an implant. Mombelli (2002),8
(1) The disturbance and/or removal of the bacterial biofilm in the peri-
implant pocket
(2) Decontaminationand conditioning of the surface of the implant
(3) Correction via reduction or elimination of sites that cannot be adequately
maintained by oral hygiene measures
(4) Establishment of an effective plaque control regime
(5) Re-osseointegration
suggests five considerations in the therapy of peri-implantitis:
Management
A hygienic phase should be started which will improve the patient's
hygiene level through a process of remotivation and reinstruction with
regard to plaque control.
The implant neck should be accessible to the patient so that hygiene
can be maintained even if this means modifying the superstructures.*
Management
* Non-surgical treatment of peri-implant mucositis and peri-implantitis: a literature review.
Renvert S, Roos-Jansaker A-M, Claffey N. 2002
Management
The “cumulative interceptive supportive therapy”(CIST),37 suggests a
protocol for the monitoring of healthy implants and the interception of peri-
implant diseases (Fig.3).
Management
This protocol relies on PPD, BOP and radiographic evidence of bone loss.
As each parameter becomes more severe, more complex treatment is
introduced, with each subsequent treatment incorporating that of the
previous.
For example, according to this protocol, if a PPD of 6mm is displayed,
positive for BOP and greater than 2mm bone loss, combination therapy of A
+ B + C + D is instituted.
Protocol A (mechanical debridement) : In case of implants with
evident plaque and/or calculus deposits adjacent to only slightly
inflamed periimplant tissues (Bleeding On Probing is positive)
Protocol B (antiseptic treatment): It is performed in
situation where in addition to plaque and BOP, probing
depth in increased up to 4-5 mm. Chlorhexidine
digluconate either in the form of daily rinse of 0.1%,
0.12% or 0.2 or as a gel applied to the site of desired
action.
Management
Cumulative interceptive supportive therapy (CIST) protocol is divided into
four stages of treatment: **
Protocol C (antibiotic treatment): When probing depth value of the
periimplant sulcus or pocket increases to 6 mm or more. Beside
the protocol A and B, an antibiotic directed at the elimination of
gram negative anaerobic bacteria is administrated.
Protocol D (regenerative or resective therapy): Only if
infection is controlled successfully by A, B and C as evidenced
by an absence of suppuration and reduced edema. It is aimed
to restore the bony support of the implant by means of
regenerative techniques. **
Management
E. Explantation using specially designed instruments
Management
Decision trees for the diagnosis and interception of peri-implantitis have
been suggested and the complexity of some of these regimes is reflective
of our current understanding(or lack of) about the etiology of peri-
implantitis.
Management
*PD denotes probing depth, and BOP bleeding on probing
Implant reconstructions in periodontally susceptible patients, Stanley Man-Lung Lai *, Kwan-Yat Zee), Esmonde F.
Corbet Hong Kong Dental Journal 2008;5:11-8
Decision tree for C.I.S.T
A systematic review for 25 animal studies for re-osseointegration on
previously contaminated surface gives the following results (Renvert et al.
2009 Clinical Oral Implants Research)
Recent Study
Open flap debridement combined with implant surface decontamination is
scarcely documented.
No single method of implant surface decontamination (e.g. hydrogen
peroxide, saline irrigation, Chlorhexidine irrigation, citric acid, air-powder
abrasive, and laser) can be considered superior.
A complete fill of the osseous defect by applying the principles of GBR is
unpredictable, only a partial resolution of the defect may be expected. *
Regenerative procedures using bone grafts, bone substitutes or GBR do
not yield predictable outcomes.
It is unknown whether the use of systemic antibiotics is required or not.
Recent Study
Biologic complications, prevention and management, Giovanni E. Salvi.
(ITI World Symposium, 2010)
The main issue is prevention
Prevention
1 ) Suitable patient selection
2 ) Infection control
Implants should not be placed if the
infection cannot be controlled by the
dentist or by the patient.
Great care should be taken with implant placement so as to avoid damaging
the host bone. The implant must at no time be contaminated in order to
prevent retrograde peri-implantitis.
3 ) Hygienic restoration design
The prosthetic reconstruction must be placed in such way that it is accessible to
hygiene at the periimplant area.
Accessibility
Not hygienic restoration design (but with good aesthetics) -
Poor design led to high risk of failure
Not accessible crowns and consecuent bone destruction led
to high risk of failure
In cases where aesthetics and hygiene come into conflict, the patient should be
informed about the consequences that restoration with no access to hygiene can
lead to failure.
4 ) Periodic recall visits
Periodical clinical examination should
include:
Probing: Bleeding on probing is
indicative of mucosal inflammation and
is a warning sign us about supporting
tissue loss.
Check up for presence of suppuration.
Radiographs. They should be taken to
evaluate the supporting bone levels,
especially when all the clinical symptoms
suggest the presence of peri-implantitis.
5 ) Early detection of pathologies
Pathologies should be treated at an early stage. The sooner they are
detected, the simpler the treatment will be.
References:
Peri-implant diseases: diagnosis and risk indicators. Heitz-Mayfield LJA.
Peri-implantitis in partially edentulous patients: association with inadequate plaque control. Giovanni Serino,
Christer Ström
Conclusions
Peri-implantitis is arguably one of the most significant risk factors associated
with late implant failures.
The relevance, contribution and impact of other factors such as implant
surfaces, smoking, history of chronic periodontitis and occlusal loading remains
obscure and undoubtedly further long term studies are necessary for
clarification.
Despite a projected increase in the incidence of peri-implantitis, the clinician
is faced with a difficult decision-making process from beginning to end. It must
be recognized that peri-implantitis is a multifactorial disease process, which may
include factors such as, host immune response and susceptibility, microbiology,
host modifying factors and local environment.
So far, single case presentations have provided evidence that bone fill of
perimplantitis defects resulting from previous perimplantitis may be achieved
following anti infective therapy and using biological principle of guided tissue
regeneration GTR
(Lehmann et al 1991; Hammerle et al 1995; Persson et al 1996).
However, the re-osseointegration of a previously contaminated implant surface
into regenerated bone has not yet been demonstrated hisotologically
(Wetzel et al. 1999).
Nevertheless, the fact that new bone does fill osseous defects, as documented
by an increase in radiographic bone density, represents a healing process most
likely resulting in further implant stability over time*1.
Conclusions
Clinical Case
Peri-
Implantitis
Protocol
A,B,C,D
Loading
3 Years
Follow up
X-Rays
Review
Limited scientific evidence is available to endorse or recommend a specific
modality for treatment and it seems that like periodontal disease, one
regime may be successful in one patient and not another.
Take home message
Until further research is available, the clinician should make a clinical
judgment based on the individual case using a rational and evidence-
based approach.
C.I.S.T protocol therapy can facilitate remodeling adjacent to the bone-
implant interface; the dynamic nature of the bone and its ability to respond to
changes can bring long term success if treated adequately with patience. In
the previous shown case C.I.S.T protocol was rigidly followed which resulted
in salvaging an otherwise lost implant.
Illustrations and demo pictures adapted from internet open
sources.
Clinical case pictures is courtesy of Dr. Ninette Banday, Dr. Abdul Naser Tamim, Dr. Arif Ali Al Juniabi
Thank you
Dr. Abdul Naser Tamim &
Dr. Arif Al Junaibi
atfahmi@ahs.ae
aali@ahs.ae
References:
1. Mombelli A, Lang NP. The diagnosis and treatment of perimplantitis .
Periodontol 2000 1998; 17:6376.
2. Alsaadi G, Quirynen M, Komárek A, van Steenberghe D. Impact of local and
systemic factors on the incidence of oral implant failures, up to abutment
connection. J Clin Periodontol 2007; 34:6107.
3. Koldsland OC, Scheie AA, Aass AM. Prevalence of implant loss and the
influence of associated factors. J Periodontol 2009; 80:106975.
4. Klokkevold PR, Han TJ. How do smoking, diabetes, and periodontitis
affect outcomes of implant treatment? Int J Oral Maxillofac Implants 2007;
22(Suppl.):173202.
5. Albrektsson T, Zarb G, Worthington P, Eriksson AR. The long term efficacy of
currently used dental implants: a review and proposed criteria of success. Int J
Oral Maxillofac Implants. 1986; 1:11-25.
6. Lang NP, Mombelli A, Tonnetti MS, Bragger U, Hammerle CH. Clinical trials on
therabies of peri-implant infections. Ann Periodontol 1997; 2:343-356.
7. Niklaus P. Lang, Thomas G. Wilson, Esmonde F. Biological complications
with dental implants: their prevention, diagnosis and treatment. Corbet 2000
Clinical Oral Implants Research Supplement No.1 Volume 11. 2000.
8. Berglund T, Person L, Kline B. J. A systematic review of the incidence
of biological and technical complications in implant dentistry reported in
prospective longitudinal studies of the last 5 years. Clin Periodontal 2002;
29(3):197-212.
9. Mombelli A, Lang NP. Antimicrobial treatment of peri-implant infections . Clin
Oral Implants Res 1992; 3:162-168.
10. Mombelli A, Feloutzis A, Bragger U, Lang NP. Treatment of peri-implantitis by
local delivery of tetracycline. Clinical, microbiological and radiological results .
Clin Oral Implants Res 2001; 14:404-411.
11. Soren Schou, Tord Berglundh, Niklaus P. Lang. Surgical treatment of peri
implantitis. Int J Oral Maxillofac Implants 2004; 19: 141.
12. Esposito M, Worthington HV, Coulthard P, Jokstad A. Interventions for replacing missing teeth: maintaining
and re-establishing health tissue around
implants. Cochrane Database Syst. Rev 2002 ;( 3):CD003069
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
The objective of this study was to assess the outcome of dental implants inserted at the Institute of Clinical Odontology, University of Oslo, between 1990 and 2005. The prevalence of implant loss and the factors associated with the outcome were studied. A total of 164 subjects were invited to participate in this cross-sectional project, of whom 55 were unable, leaving 109 volunteers available for examination. The study population included 69 females and 40 males with a mean age of 43.8 years at the time of implant insertion (range, 18 to 80 years). At the subject level, the mean time from implant loading to the present examination was 8.4 years (range, 1.1 to 16.0 years). The participants were examined clinically and radiographically and interviewed regarding general health and habits. The 109 examined subjects had been treated with 374 implants. Eighteen implants (4.8%) were lost in 10 subjects (9.2%). Eleven implants were lost before loading, three were lost during the first 5 years after loading, and four were lost 5 to 10 years after loading. No implants were lost after >10 years of loading. The loss of oral implants was significantly associated with a history of smoking and periodontitis (P <0.05). The inserted implants showed a high survival rate, especially after the first year of insertion, even though the subjects were not maintained by specialists. All late implant losses were preceded by an early loss. Implant loss was significantly associated with smoking and periodontitis.
Article
Full-text available
Criteria for the evaluation of dental implant success are proposed. These criteria are applied in an assessment of the long-term efficacy of currently used dental implants including the subperiosteal implant, the vitreous carbon implant, the blade-vent implant, the single-crystal sapphire implant, the Tübingen implant, the TCP-implant, the TPS-screw, the ITI hollow-cylinder implant, the IMZ dental implant, the Core-Vent titanium alloy implant, the transosteal mandibular staple bone plate, and the Brånemark osseointegrated titanium implant. An attempt has been made to standardize the basis for comments on each type of implant.
Article
Full-text available
Peri-implant infections are pathological conditions which are normally localized in the soft tissues surrounding an oral implant. They may range from a rather localized mucositis lesion reflecting the host response to a bacterial challenge to a more advanced lesion "termed peri-implantitis" when previously osseointegrated oral implants have been partially disintegrated; i.e. have lost alveolar bone around the implant. Usually these lesions start as a result of plaque accumulation and show similar progression as observed around teeth. Muscositis seems to be a prerequisite for the following peri-implantitis. However, the factors involving the transition to a more advanced lesion are still not known. Logically, the therapy for peri-implant infection has to be related to antibacterial treatment prior to the attempt to surgically regenerate peri-implant alveolar bone lost as a result of the infection. In order to diagnose these lesions at an early stage frequent assessments of clinical parameters are needed during maintenance therapy. The anti-infective treatment may intercept the development of the lesion. Following mechanical debridement of plaque deposits the application of efficacious antiseptics (chlorhexidine) is a necessity. Following this, antibiotics may cumulatively be applied to control the infection. Only a few longitudinal studies have documented the efficacy of such treatment regimens, and controls have generally not been available for ethical reasons. In regenerating the lost jaw bone only case reports are available today. Controlled animal studies will have to be performed to document the possibility of re-osseointegration and the factors influencing predictability.
Article
The purpose of this study was to investigate the possibility of antimicrobial treatment of peri-implant infections associated with a periodontitis-like subgingival microbiota. Nine partially or fully edentulous patients with titanium hollow cylinder implants were selected which showed loss of bone and probing depths > or = 5 mm on one or several implants after at least 6 months following installation. They also yielded subgingival microbial samples with > or = 10(6) CFU/ml, including > or = 20% gram-negative anaerobic bacteria. The treatment included mechanical cleaning, irrigation of all peri-implant pockets > 3 mm with 0.5% chlorhexidine and systemic antimicrobial therapy (1000 mg ornidazole for 10 consecutive days). After therapy, bleeding scores decreased immediately and, over a one-year observation period, remained significantly lower than before treatment. A significant gradual reduction in mean probing depths was detected over this one-year period; only one case showed no improvement of local probing depth. Microbiological parameters indicated an instantaneous quantitative and qualitative change following treatment. Subsequently, several of these parameters tended to shift back towards pretreatment values. In the second half of the observation period, however, this tendency was reversed, and levels significantly different from baseline were eventually established. This study demonstrated that treatment aiming at reducing the subgingival bacterial mass and suppressing the anaerobic segment had a beneficial effect in patients suffering from peri-implantitis.
Article
Biofilms form on all hard non-shedding surfaces in a fluid system, i.e. both on teeth and oral implants. As a result of the bacterial challenge, the host responds by mounting a defence mechanism leading to inflammation of the soft tissues. In the dento-gingival unit, this results in the well-described lesion of gingivitis. In the implanto-mucosal unit, this inflammation is termed "mucositis". If plaque is allowed to accumulate for prolonged periods of time, experimental research has demonstrated that "mucositis" may develop into "periimplantitis" affecting the periimplant supporting bone circumferentially. Although the bony support may be lost coronally, the implant still remains osseointegrated and hence, clinically stable. This is the reason why mobility represents an insensitive, but specific diagnostic feature of "periimplantitis". More sensitive and more reliable parameters of developing and existing periimplant infections are "bleeding on probing", "probing depths" and radiographic interpretation of conventional or subtraction radiographs. Depending on the diagnosis made continuously during recall visits, a maintenance system termed Cumulative Interceptive Supportive Therapy (CIST) has been proposed.
Article
The purpose of this study was to investigate the clinical, microbiological and radiological effects of peri‐implantitis therapy by local delivery of tetracycline. In 25 partially edentulous patients, 30 implants with radiographic evidence of circumferential bone loss, and peri‐implant probing depths ≥5 mm were treated with polymeric tetracycline HCl‐containing fibers. Clinical and microbial parameters were recorded at baseline, and 1, 3, 6, and 12 months (M) after treatment. Standardized radiographs were obtained at baseline, M3, and one year after treatment. Two patients were discontinued from the study after 180 days because of persisting active peri‐implantitis with pus formation. The remaining subjects showed a significant decrease of mean peri‐implant probing depth from 6.0 to 4.1 mm (M1, P <0.001), which was maintained over 12 months. In comparison to baseline, the bleeding tendency was significantly reduced after one month, and thereafter ( P <0.001). No significant recession of the mucosal margin was noted. The radiologically determined distance from the shoulder of the implant to the bottom of the bony defect decreased slightly, but not significantly, from 5.2 to 4.9 mm. At M1, M3 and M6, mean total anaerobic cultivable bacterial counts were significantly lower than at baseline ( P <0.001). A significant decrease in frequency of detection was noted for Prevotella intermedia/nigrescens , Fusobacterium sp., Bacteroides forsythus, and Campylobacter rectus ( P <0.01). Actinobacillus actinomycetemcomitans , Porphyromonas gingivalis , and Eikenella corrodens had very low baseline frequencies that could not be significantly suppressed further. In conclusion, therapy of peri‐implantitis by local delivery of tetracycline had a positive effect on clinical and microbiological parameters.
Article
Antibacterial mouth rinses may help prevent plaque and bleeding around dental implants, but there is no evidence that electronic toothbrushes are better than ordinary toothbrushes. Missing teeth can sometimes be replaced with a dental implant, as the bone in the jaw can grow around it. However, keeping the gums around the implant healthy is important, as there is an increased chance they can be eroded by plaque and inflammation. The review found that there is no evidence from trials that powered or sonic toothbrushes are better than manual brushes, or that phosphoric gel is better for removing plaque than scraping and polishing. However, there is some evidence that Listerine antibacterial mouthwash, used twice a day (as well as brushing) can help keep the gums healthy.
Article
Surgical treatment of peri-implantitis lesions can be performed in cases with considerable pocket formation (larger than 5 mm) and bone loss after the acute infection has been resolved and proper oral hygiene has been instituted. A literature review was conducted to ascertain current knowledge about surgical treatment options for peri-implantitis around commercially pure titanium implants. Recently reported animal studies involving implants with a rough surface indicate that considerable bone regeneration and re-osseointegration can be obtained by using membrane-covered autogenous bone graft particles. However, comparisons of the treatment outcomes in studies involving humans and animals are difficult because of differences in implant type, graft type, and evaluation protocols. In addition, different treatment procedures, including implant surface decontamination methods, have been used. Therefore, further long-term studies in humans involving sufficient numbers of subjects are needed to provide a solid basis for recommendations regarding the surgical treatment of peri-implantitis. Moreover, the encouraging treatment outcomes of regenerative procedures recently revealed in animal experiments and applied in the treatment of peri-implantitis around implants with sandblasted/acid-etched surfaces have not yet been documented for implants with other surfaces, especially turned surfaces. Numerous implant surface decontamination methods have been suggested as part of the surgical treatment of peri-implantitis. Decontamination of affected implants with titanium plasma-sprayed or sandblasted/acid-etched surfaces may most easily and effectively be achieved by applying gauze soaked alternately in chlorhexidine and saline.
Article
The aim of this retrospective study was to assess the influence of systemic and local bone and intra-oral factors on the occurrence of early implant failures, i.e. up to the abutment connection. The surgical records of 2004 consecutive patients from the total patient population who had been treated in the period 1982-2003 (with a total of 6946 Brånemark system implants) at the Department of Periodontology of the Catholic University Leuven were evaluated. For each patient the medical history was carefully checked. Data collection and analysis mainly focused on endogenous factors such as hypertension, coagulation problems, osteoporosis, hypo-hyperthyroidy, chemotherapy, diabetes type I or II, Crohn's disease, some local factors [e.g. bone quality and quantity, implant (length, diameter, location), type of edentulism, Periotest value at implant insertion, radiotherapy], smoking habits and breach of sterility during surgery. A global failure rate of 3.6% was recorded. Osteoporosis, Crohn's disease, smoking habits, implant (length, diameter and location) and vicinity with the natural dentition were all significantly associated with early implant failures (p<0.05). The indication for the use of oral implants should sometimes be reconsidered when alternative prosthetic treatments are available in the presence of possibly interfering systemic or local factors.